Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity
International Journal of Molecular Sciences · 25.08.2023 · 24 (17) · 13199
DOI: 10.3390/ijms241713199 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.08.2023. Verfasst von Marcelina J Wojewska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK. Hauptthemen laut MEDLINE: Synucleinopathies, Dementia, Parkinson Disease, Multiple System Atrophy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Alzheimer's Society, Multiple System Atrophy Trust.
Abstract (Originalsprache)
Alpha-synucleinopathies (α-synucleinopathies) such as Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) are all characterized by aggregates of alpha-synuclein (α-syn), but display heterogeneous clinical and pathological phenotypes. The mechanism underlying this heterogeneity is thought to be due to diversity in the α-syn strains present across the diseases. α-syn obtained from the post-mortem brain of patients who lived with these conditions is heterogenous, and displays a different protease sensitivity, ultrastructure, cytotoxicity, and seeding potential. The primary aim of this review is to summarize previous studies investigating these concepts, which not only reflect the idea of different syn strains being present, but demonstrate that each property explains a small part of a much larger puzzle. Strains of α-syn appear at the center of the correlation between α-syn properties and the disease phenotype, likely influenced by external factors. There are considerable similarities in the properties of disease-specific α-syn strains, but MSA seems to consistently display more aggressive traits. Elucidating the molecular underpinnings of heterogeneity amongst α-synucleinopathies holds promise for future clinical translation, allowing for the development of personalized medicine approaches tackling the root cause of each α-synucleinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.
ORCID-Profile: Marcelina J Wojewska, Javier Alegre-Abarrategui
Förderung
- Medical Research Council
- Alzheimer's Society
- Multiple System Atrophy Trust
- Imperial College London Medical Research Council Doctoral Training Partnership
- Alzheimer’s Society
- Pathological Society
Zitieren
APA
Wojewska, M. J., Otero-Jimenez, M., Guijarro-Nuez, J., & Alegre-Abarrategui, J. (2023). Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity. International Journal of Molecular Sciences, 24(17), 13199. https://doi.org/10.3390/ijms241713199
Vancouver
Wojewska MJ, Otero-Jimenez M, Guijarro-Nuez J, Alegre-Abarrategui J. Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity. International Journal of Molecular Sciences. 2023;24(17):13199. doi:10.3390/ijms241713199
BibTeX
@article{Wojewska2023,
author = {Wojewska, Marcelina J and Otero-Jimenez, Maria and Guijarro-Nuez, Jose and Alegre-Abarrategui, Javier},
title = {Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {17},
pages = {13199},
doi = {10.3390/ijms241713199}
}
EUVIMED